Zhang, Yuanyuan
Li, Ning
Yuan, Guangwen
Yao, Hongwen
Zhang, Die
Li, Nan
Zhang, Gongyi
Sun, Yangchun
Wang, Wenpeng
Zeng, Jia
Xu, Ningzhi
Liu, Mei
Wu, Lingying
Article History
Received: 21 June 2021
Accepted: 10 January 2022
First Online: 8 February 2022
Declarations
:
: Specimen collection and clinicopathological data review protocols used in this study were approved by the Ethics Committee of Cancer Hospital, CAMS (Chinese Academy of Medical Sciences & Peking Union Medical College (NCC2018-070 and NCC2019C-010). This study was performed in accordance with the International Ethical Guidelines for Biomedical Research Involving Human Subjects (CIOMS) and neither of the procedures conducted interfered with the treatment plan of the patient. All animal experiments were approved by the Beijing Municipal Science and Technology Commission and conducted in accordance with the relevant guidelines. The Ethics approval number of animal experiments: NCC2019A037.Specimens were obtained with the informed consent of all patients involved. These specimens collected included primary cell culture and constructed continuing cell lines.
: All of the authors consent for publication.
: The authors declare that they have no competing interests.